Trials / Completed
CompletedNCT05226884
Intermediate Vision in Patients With Clareon IOLs Compared to Eyhance IOLs
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 310 (actual)
- Sponsor
- Berkeley Eye Center · Academic / Other
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Accepted
Summary
Compare visual outcomes in patients with bilateral Clareon Monofocal IOLs versus bilateral Eyhance IOLs.
Detailed description
This is a non-interventional prospective, comparative study of the outcomes for patients following successful, uncomplicated cataract surgery. All patients will have had bilateral implantation of an Eyhance IOL (DIB00/DIU\*\*\*) or Clareon IOL (CNA0T0) at the time of uncomplicated cataract surgery. These patients will then be assessed post-operatively to compare distance and intermediate visual acuities and a defocus curve in patients with bilateral Clareon Monofocal IOLs versus bilateral Eyhance IOLs. Patients will be assessed for corrected binocular distance and intermediate vision.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Visual Acuity | Measurement of distance and intermediate visual acuity at variety targeted correction. |
| DIAGNOSTIC_TEST | Defocus Curve | Measurement of a defocus curve |
Timeline
- Start date
- 2021-11-30
- Primary completion
- 2022-08-06
- Completion
- 2022-08-06
- First posted
- 2022-02-07
- Last updated
- 2024-11-15
- Results posted
- 2024-11-15
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05226884. Inclusion in this directory is not an endorsement.